Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurumi Y Horiuchi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Drug Discovery Today. Technologies|January 3, 2016
Challenges in profiling and lead optimization of drug discovery for methyltransferasesKurumi Y Horiuchi
Drug Discovery Today|June 24, 2006
Chemical microarray: a new tool for drug screening and discoveryHaiching Ma, Kurumi Y Horiuchi
Methods in Molecular Biology (Clifton, N.J.)|August 10, 2010
Fluorescence polarization and time-resolved fluorescence resonance energy transfer techniques for PI3K assaysKurumi Y Horiuchi, Haiching Ma
Chemical Biology & Drug Design|February 24, 2006
Biochemical microarrays for studying chemical biology interaction: DiscoveryDot technologyKurumi Y Horiuchi, Yuan Wang, Haiching Ma
Journal of Biomolecular Screening|November 30, 2005
Microarrays for the functional analysis of the chemical-kinase interactomeKurumi Y Horiuchi, Yuan Wang, Scott L Diamond, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 10, 2010
Chemical microarrays: a new tool for discovery enzyme inhibitorsShuguang Liang, Wei Xu, Kurumi Y Horiuchi, et al.
Assay and Drug Development Technologies|May 6, 2005
Nanoliter homogenous ultra-high throughput screening microarray for lead discoveries and IC50 profilingHaiching Ma, Kurumi Y Horiuchi, Yuan Wang, et al.
Cell Reports|January 19, 2016
Kinase Inhibitor Profiling Reveals Unexpected Opportunities to Inhibit Disease-Associated Mutant KinasesKrisna C Duong-Ly, Karthik Devarajan, Shuguang Liang, et al.
Assay and Drug Development Technologies|April 6, 2013
Assay development for histone methyltransferasesKurumi Y Horiuchi, Mia M Eason, Joseph J Ferry, et al.
Assay and Drug Development Technologies|June 13, 2015
Development and Use of Assay Conditions Suited to Screening for and Profiling of SET-Domain-Targeted Inhibitors of the MLL/SET1 Family of Lysine MethyltransferasesJoseph J Ferry, Robert F Smith, Natalie Denney, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Drug Discovery Today. Technologies|January 3, 2016
Challenges in profiling and lead optimization of drug discovery for methyltransferasesKurumi Y Horiuchi
Drug Discovery Today|June 24, 2006
Chemical microarray: a new tool for drug screening and discoveryHaiching Ma, Kurumi Y Horiuchi
Methods in Molecular Biology (Clifton, N.J.)|August 10, 2010
Fluorescence polarization and time-resolved fluorescence resonance energy transfer techniques for PI3K assaysKurumi Y Horiuchi, Haiching Ma
Chemical Biology & Drug Design|February 24, 2006
Biochemical microarrays for studying chemical biology interaction: DiscoveryDot technologyKurumi Y Horiuchi, Yuan Wang, Haiching Ma
Journal of Biomolecular Screening|November 30, 2005
Microarrays for the functional analysis of the chemical-kinase interactomeKurumi Y Horiuchi, Yuan Wang, Scott L Diamond, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 10, 2010
Chemical microarrays: a new tool for discovery enzyme inhibitorsShuguang Liang, Wei Xu, Kurumi Y Horiuchi, et al.
Assay and Drug Development Technologies|May 6, 2005
Nanoliter homogenous ultra-high throughput screening microarray for lead discoveries and IC50 profilingHaiching Ma, Kurumi Y Horiuchi, Yuan Wang, et al.
Cell Reports|January 19, 2016
Kinase Inhibitor Profiling Reveals Unexpected Opportunities to Inhibit Disease-Associated Mutant KinasesKrisna C Duong-Ly, Karthik Devarajan, Shuguang Liang, et al.
Assay and Drug Development Technologies|April 6, 2013
Assay development for histone methyltransferasesKurumi Y Horiuchi, Mia M Eason, Joseph J Ferry, et al.
Assay and Drug Development Technologies|June 13, 2015
Development and Use of Assay Conditions Suited to Screening for and Profiling of SET-Domain-Targeted Inhibitors of the MLL/SET1 Family of Lysine MethyltransferasesJoseph J Ferry, Robert F Smith, Natalie Denney, et al.
Pageof 2